| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0895-3988(15)30116-1 |
| P698 | PubMed publication ID | 26695364 |
| P2093 | author name string | Lei Zhang | |
| Wei Ping Jia | |||
| Hua Ting Li | |||
| Ling Ling Qian | |||
| Qi Chen Fang | |||
| P2860 | cites work | Gut Microbiota and Its Possible Relationship With Obesity | Q22241118 |
| Enterotypes of the human gut microbiome | Q24489818 | ||
| Obesity alters gut microbial ecology | Q24531503 | ||
| An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice | Q24601321 | ||
| Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 | ||
| Pathogen recognition and inflammatory signaling in innate immune defenses | Q24643034 | ||
| A core gut microbiome in obese and lean twins | Q24649648 | ||
| Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity | Q26828547 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Host-bacterial mutualism in the human intestine | Q27861037 | ||
| Sensing of bacteria: NOD a lonely job | Q28278372 | ||
| Therapeutic potential of fecal microbiota transplantation | Q28298108 | ||
| Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects | Q28476357 | ||
| Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice | Q28546415 | ||
| Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms | Q28730663 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Q29615051 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| Host-gut microbiota metabolic interactions | Q29615104 | ||
| Functional interactions between the gut microbiota and host metabolism | Q29616815 | ||
| Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome | Q29616853 | ||
| Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis | Q33750735 | ||
| Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers | Q34024108 | ||
| Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice | Q34097751 | ||
| Effect of metformin on metabolic improvement and gut microbiota | Q34261321 | ||
| Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
| An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice | Q34785134 | ||
| Role of microorganisms in the evolution of animals and plants: the hologenome theory of evolution | Q34786172 | ||
| Human colonic microbiota associated with diet, obesity and weight loss | Q34823807 | ||
| Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? | Q34943068 | ||
| Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice | Q35033766 | ||
| Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. | Q35062300 | ||
| NOD1 activators link innate immunity to insulin resistance | Q35180089 | ||
| Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation | Q35547292 | ||
| Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity | Q35567297 | ||
| Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice | Q35575848 | ||
| Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome | Q35595578 | ||
| Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: A pilot study | Q35620403 | ||
| Rehmannia glutinosa reduced waist circumferences of Korean obese women possibly through modulation of gut microbiota | Q35682074 | ||
| Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. | Q35693573 | ||
| Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing | Q35742114 | ||
| Gut microorganisms, mammalian metabolism and personalized health care | Q36094303 | ||
| Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations | Q36246939 | ||
| Debugging how bacteria manipulate the immune response. | Q36739044 | ||
| Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. | Q36914673 | ||
| Energy contributions of volatile fatty acids from the gastrointestinal tract in various species | Q37911399 | ||
| The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection | Q38255957 | ||
| Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis | Q38308819 | ||
| NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes | Q38334079 | ||
| Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice | Q38336577 | ||
| Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. | Q38383259 | ||
| Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial | Q39109399 | ||
| NOD2 Activation Induces Muscle Cell-Autonomous Innate Immune Responses and Insulin Resistance | Q39647567 | ||
| TGR5-mediated bile acid sensing controls glucose homeostasis | Q39805262 | ||
| Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine | Q41445793 | ||
| Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. | Q42175864 | ||
| The origins and drivers of insulin resistance | Q42274713 | ||
| Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects | Q42918043 | ||
| Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. | Q43091069 | ||
| Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice | Q43253088 | ||
| What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat Clostridium difficile Infection? | Q44424789 | ||
| The gut microbiota and obesity: from correlation to causality | Q44559588 | ||
| Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia | Q45100284 | ||
| Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats | Q47175009 | ||
| A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes | Q48984972 | ||
| Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. | Q51353616 | ||
| Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. | Q52541251 | ||
| A gut prediction | Q59085997 | ||
| Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists | Q83885599 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 839-47 | |
| P577 | publication date | 2015-11-01 | |
| P1433 | published in | Biomedical and Environmental Sciences | Q15816459 |
| P1476 | title | Effect of the Gut Microbiota on Obesity and Its Underlying Mechanisms: an Update | |
| P478 | volume | 28 |
Search more.